Join the latest movement to create lupus awareness by joining the #ISingForLupusChallenge.
Upcoming Events See all events >
Join in the fight to end lupus now in Cincinnati!
Latest News See all stories >
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.
The collaboration between Exagen and GSK will raise awareness of Exagen's AVISE diagnostic and monitoring tests among healthcare professionals around the world.
Are you participating in a Walk to End Lupus Now event? We have uploaded materials to better assist you and your team through your fundraising efforts!
The Lupus Foundation of America, Greater Ohio Chapter (LFA, GOC), in partnership with RAMA Consulting, Inc. was awarded funding from the Ohio Department of Health to develop and promote a statewide Lupus Education Initiative, and provide a toolkit for healthcare professionals.
Researchers at Cincinnati Children’s Hospital Medical Center are looking for young adults age 18 to 30 that have skin lupus or SLE-CL to participate in the study of an investigational drug.